Biliary complications following liver transplantation: Single-center experience over three decades and recent risk factors

doi:10.4254/wjh.v9.i3.147

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7574)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-5) series.

Item

Count

PDF

511

WORD

425

HTML

2285

Figures (1-4)

148

Tables (1-5)

172

Sum=3541

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

540

Download

1031

Sum=1571

Publishing Process of This Article

Item

Count

Browse

984

Download

1478

Sum=2462

Jan 28, 2017 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Jan 28, 2017; 9(3): 147-154
Published online Jan 28, 2017. doi: 10.4254/wjh.v9.i3.147

Table 1 Clinical characteristics of recipient data

Variable	Mean (SD)	Median (range)	n (% of cohort)
MELD	21 (11.5)	18 (6-40)
BMI	24.2 (4.5)	24.7 (15.1-40)
Days on the waiting list	277 (41.5)	143 (0-4299)
Male: Female	915 (57%) to 692 (43%)
Age	46.1 (12)	47.5 (18-73.6)
ICU stay in days	23 (33)	9 (1-276)
Pre-transplant PVT			143 (9)
Creatinine (μmol/L)	121 (92)	86 (38-707)
Bilirubine (μmol/L)	177 (209)	72 (7-930)
Indication HCC			244 (15)
Indication PSC			153 (9.5)
Indication ALF			137 (8.5)
Indication HCV cirrh.			101 (6.3)
Indication alc. cirrh.			104 (6.4)
Indication biliary dis.			326 (20.3)

MELD: Model of End-Stage Liver Disease; BMI: Body mass index; ICU: Intensive care unit; PVT: Portal vein thromboses; HCC: Hepatocellular carcinoma; PSC: Primary sclerosing cholangitis; ALF: Acute liver failure; HCV: Hepatitis C virus.

Citation: Kaltenborn A, Gutcke A, Gwiasda J, Klempnauer J, Schrem H. Biliary complications following liver transplantation: Single-center experience over three decades and recent risk factors. World J Hepatol 2017; 9(3): 147-154
URL: https://www.wjgnet.com/1948-5182/full/v9/i3/147.htm
DOI: https://dx.doi.org/10.4254/wjh.v9.i3.147